Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report

Creative Commons License

Borekci E.

AFRICAN HEALTH SCIENCES, cilt.19, sa.2, ss.2290-2293, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Sayı: 2
  • Basım Tarihi: 2019
  • Doi Numarası: 10.4314/ahs.v19i2.55
  • Dergi Adı: AFRICAN HEALTH SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2290-2293
  • Yozgat Bozok Üniversitesi Adresli: Evet

Özet

Rivaroxaban is one of the new anti-coagulants that inhibit Factor Xa and rarely cause rectus sheath hematoma and retroperitoneal haemorrhage which are uncommon, life-threatening complications. Here is a case of an elderly patient on rivaroxaban therapy for the stroke prevention in non-valvular atrial fibrillation who developed rectus sheath hematoma and retroperitoneal bleeding.